Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

T. Rowe Price Capital Appreciation Fund Advisor Class (PACLX)

27.47
Net Asset Value
+0.11%
1 Day
+6.06%
Year-to-Date
Overall Morningstar Rating
Moderate allocation
Style or Category
No Load
Sales Expenses
1.01%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund normally invests at least 50% of its total assets in stocks and the remaining assets are generally invested in convertible securities, corporate and government debt (including mortgage- and asset-backed securities), and bank loans (which represent an interest in amounts owed by a borrower to a syndicate of lenders), in keeping with the fund's objective. The fund may also invest up to 25% of its total assets in foreign securities.

Performance

1 month+2.42% 3 years+15.24%
3 months+3.19% 5 years+13.70%
1 year+12.59% Since inception+8.33%
Data through --

Peer Comparisonvs. Moderate allocation

 PACLXCategory
Performance 5-yr return+13.70%+10.38%
Expense ratio1.01%1.24%
Risk 5 year sharpe ratio1.601.21
Net assets$23.9B$2.9B
Average market cap$37.9B$48.7B
Average P/E22.318.8
Portfolio turnover72%72%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyT. Rowe Price
Fund manager & tenureDavid Giroux / 9 Years
Minimal initial investment$2,500.00
Minimum IRA investment--

Holdings

U.S. stock52.56%
Fixed income27.32%
Cash11.55%
International stock6.01%
Other2.57%
Top 5 Sectors
Portfolio weighting
Financial service 19.82%
Industrial materials 16.26%
Healthcare 12.96%
Hardware 11.73%
Energy 10.00%
Top 10 Holdings
Portfolio weighting
DHR Danaher Corp4.40%
MMC Marsh & McLennan Companies Inc3.33%
TMO Thermo Fisher Scientific Inc2.94%
FISV Fiserv Inc2.89%
AZO Autozone Inc2.84%
BK Bank of New York2.83%
AGN Allergan2.33%
-- 1.87%
BDX Becton, Dickinson and Co1.71%
PNR Pentair plc1.66%